Methods of treating depressive disorders
AssigneeXenon Pharmaceuticals Inc.
InventorsCynthia Louise Harden, Gregory N. Beatch
Life of this patent
Estimating the term…
Abstract
In certain embodiments, the present disclosure is directed to methods for treating depressive disorders in a human, wherein the methods comprise orally administering a therapeutically effective amount of N-[4-(6-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)-2,6-dimethylphenyl]-3,3-dimethylbutanamide (Compound A), to the human in need thereof. The present disclosure is further directed to various improved methods of therapy and administration of Compound A.
Claims21
A method of treating a depressive disorder in a human in need thereof, comprising administering a therapeutically effective amount of Compound A to the human;
- wherein Compound A is N-[4-(6-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)-2,6-dimethylphenyl]-3,3-dimethylbutanamide;
- wherein Compound A is orally administered to the human under fed conditions.
Dependencies are inferred from the claim text.